  
User Testing Services
Additional Useful Information
Important points to consider
The leaflet that is user tested must be 'as close as possible
to the final version which patients will find in the pack',
i.e. User Testing cannot be carried out on a 'text only'
document* (*Reference
1). CambReg has worked with clients' own
production/design departments or undertaken responsibility
for the design and production of mock-up leaflets.
The 'Important information' required to use the product safely
and effectively must be clearly identified. It is often the
case that only the client can identify the key messages for
the product.
Users must be able to find, understand and act appropriately
on all the key items of information.
The exact requirements for the format and content of a User
Test report and acceptable user testing strategies differ
between Health Authorities. CambReg has performed tests which
have been submitted to Health Authorities across Europe.
How can leaflets be improved?
Good practice for the writing and design of package leaflets
is well established and the MHRA has published a report giving
advice on this*. (*Reference
2).
The following are examples of problem areas we have identified
prior to and during the testing process:
Problems with design and layout:
-
Inappropriate use of colour
-
Text too small
-
Information which is perceived to be in the 'wrong
section' by users
-
Insufficient differentiation between headings and body
text
-
Inappropriate use of text features for emphasis e.g.
italics, uppercase, underlining etc.
-
Text too dense, not enough bullet points.
Problems with text:
-
Overuse of technical language and product name
- Side effect information presented in the wrong order and without frequency indicators
-
Lack of clear advice on what action to take and when,
especially in the 'what to do if you forget to
take' section
-
Indirect language
-
No reference to availability of different formats
*References
1.
Additional Q’s and A’s in relation to the new
legal requirement to undertake consultation with target patient
groups (Compliance with article 59(3) of Council Directive
2001/83/EC) (June 06)
2. Always
Read the Leaflet (July 05) |
